Union Health Ministry Tightens Rules for Alcohol-Based Drug Formulations

Key Facts

• On 10 July 2026, the Union Health Ministry amended the Drugs Rules, 1945, to regulate medicinal products with high ethyl alcohol content.
• The amendment removes exemptions under Schedule K for alcohol-based drug formulations containing more than 12% v/v ethyl alcohol when they exceed 30 ml in volume.
• Such formulations will now be categorized under Schedule H1, which mandates manufacturing and sale licenses under the Drugs and Cosmetics Act, 1940, as well as prescription-only dispensing and maintenance of pharmacy sale records.
• The amendment addresses concerns raised by state governments about misuse of certain medicinal products containing 80-90% v/v ethyl alcohol for intoxication.
• The revised rules harmonize alcohol content limits with those in traditional medicines: Ayurvedic, Siddha, and Unani medicines permit up to 16% ethyl alcohol, while Homeopathic medicines permit up to 12%.
• The amended rules will be implemented approximately six months after Gazette notification, around January 2027.

Background & Context

The Drugs and Cosmetics Act, 1940, and the accompanying Drugs Rules, 1945, provide the regulatory framework for manufacture, sale, and distribution of drugs in India. Under these rules, medicines are categorized in schedules that determine the regulatory controls applicable, including prescription requirements and record-keeping.

Schedule H1 includes medicines that require prescription from a registered medical practitioner and mandates pharmacies to maintain sales records. Previously, Schedule K contained exemptions for certain medicinal preparations from licensing and other controls.

Some alcohol-based medicinal formulations with high alcohol content were exempted under Schedule K, but misuse of such medicines for intoxication by consuming products with very high alcohol concentration prompted the Health Ministry to amend the rules.

The amendment removes exemptions for formulations containing more than 12% ethyl alcohol when volume exceeds 30 ml, bringing them under stricter regulatory control to curb misuse.

Why This Matters for Exams

This regulatory amendment is pertinent for candidates preparing for health administration, pharmaceutical regulation, and public policy competitive examinations. It reflects the government's approach to ensuring patient safety through controlled dispensation of potentially intoxicating medicines. Understanding the timelines, regulatory schedules involved, and the link between traditional medicine alcohol limits and this amendment is essential for comprehensive knowledge in this domain.

Points to Remember

• Amendment Date: 10 July 2026
• Principal Law: Drugs and Cosmetics Act, 1940
• Key Regulation: Drugs Rules, 1945 (Schedules H1 and K)
• Alcohol Concentration Threshold: >12% v/v ethyl alcohol
• Volume Threshold: >30 ml
• Schedule Change: Alcohol formulations above thresholds removed from Schedule K exemption and placed under Schedule H1
• Prescription and licensing are mandatory for affected formulations
• Alignment: Traditional medicines alcohol limits (Ayurvedic/Siddha/Unani up to 16%; Homeopathic up to 12%)
• Implementation Timeline: Approximately January 2027, six months post-Gazette publication
• Reason: Prevent misuse of high-alcohol medicinal products for intoxication